TABLE 3:

Relationship of treatment of menopausal symptoms and self-reported quality of life (SRQoL score, possible range 1-10 with higher values = better QoL) within racial/ethnic groups: model-based estimates and significant contrasts with 95% confidence intervals

Baseline Analyses (N=2378)
	Neither	CAM only	HT only	Both	Contrast, p
Black	7.5 (7.3 - 7.7) N=501	7.6 (7.3 - 8.0) N=108	7.2 (6.8 - 7.6) N=76	7.1 (6.4 - 7.9) N=19
Chinese	7.3 (7.0 - 7.7) N=142	7.0 (6.4 - 7.6) N=32	6.3 (5.7 - 7.0) N=30	6.7 (5.7 - 7.7) N=10	HT only<Neither −1.0 (−1.6 - −0.4), p=0.002
Japanese	7.3 (6.9 −7.6) N=149	7.4 (6.9 - 7.9) N=45	7.6 (7.0 - 8.1) N=39	7.1 (6.1 - 8.1) N=11
White	7.5 (7.3 - 7.7) N=711	7.7 (7.4 - 8.0) N=171	7.6 (7.3 - 7.9) N=272	7.6 (7.1 - 8.0) N=62
Longitudinal Analyses (total number of observations = 13223)
	Neither	CAM only	HT only	Both	Contrast, p
Black	7.6 (7.4 - 7.7) n=3100	7.6 (7.3 - 7.8) n=419	7.4 (7.1 - 7.6) n=242	7.2 (6.8 - 7.6) n=43	HT only <Neither −0.21 (−0.40 - −0.02), 0.027
Chinese	7.3 (7.1 - 7.6) n=1026	7.3 (7.0 - 7.7) n=99	7.1 (6.7 - 7.4) n=111	6.9 (6.2 - 7.6) n=12
Japanese	7.4 (7.2 - 7.6) n=1070	7.3 (7.1 - 7.6) n=206	7.4 (7.1 - 7.7) n=158	7.1 (6.6 - 7.7) n=29
White	7.6 (7.4 - 7.7) n=4851	7.6 (7.5 - 7.8) n=694	7.7 (7.5 - 7.9) n=982	7.6 (7.4 - 7.9) n=181	HT only >Neither 0.11 (0.01 - 0.21), 0.030

CAM: Complementary Alternative Medicine use for menopausal symptom relief; HT: Hormone Therapy.

N of women = n of observations

Analyses adjusted for study site, baseline age, education, financial strain and medical burden.